HARTMANN GROUP, Heidenheim, Germany; Institute of Public Health, Medical Decision Making and HTA, UMIT, Hall i.T., Austria.
HARTMANN GROUP, Heidenheim, Germany; Erasmus Universiteit Rotterdam, Erasmus School of Health Policy&Management, Rotterdam, Netherlands.
J Tissue Viability. 2022 Aug;31(3):523-530. doi: 10.1016/j.jtv.2022.04.005. Epub 2022 Apr 25.
Venous leg ulcers (VLUs) are the most common hard-to-heal ulcers associated with the high humanistic and economic burden. Especially clinically challenging are moderate-to-highly exuding venous leg ulcers, and current management guidelines recommend several different wound dressings for this indication. The study aimed to determine the cost-effectiveness of managing moderate-to-highly exuding venous leg ulcers with superabsorbent wound dressings versus foams dressings in French settings from Haute Autorité de Santé perspective. For evidence synthesis decision-analytic model was developed in line with international and French good modelling practices recommendations. All model inputs were informed by data identified through systematic literature reviews that, in our best knowledge, represent the best available evidence at this moment. According to the prediction from this early stage health economic evaluation, using superabsorbent wound dressings versus foam dressings mix in patients with moderate-to-highly exuding leg ulcers in French settings will result in an improved healing rate of 2.58%, incremental HRQoL of 0.143 QALWs and total direct cost savings of € 435 (USD 473) per patient over six months period. The clinical outcomes results from this evaluation are in line with management guidelines that have recommended superabsorbent wound dressings as a first-line choice in the therapy of moderate-to-highly exuding venous leg ulcers. In addition, this evaluation demonstrates that using superabsorbent wound dressings will also lead to economic savings from the Haute Autorité de Santé perspective.
静脉性腿部溃疡(VLUs)是与高人文和经济负担相关的最常见的难以愈合的溃疡。特别是中等至大量渗出性静脉性腿部溃疡具有临床挑战性,目前的管理指南为此推荐了几种不同的伤口敷料。本研究旨在从法国 Haute Autorité de Santé 的角度,确定使用高吸收性伤口敷料与泡沫敷料治疗中等到大量渗出性静脉性腿部溃疡的成本效益。为了进行证据综合,根据国际和法国良好建模实践建议制定了决策分析模型。所有模型输入均通过系统文献综述确定,根据我们目前的最佳知识,这些综述代表了目前最佳的可用证据。根据这项早期卫生经济评估的预测,在法国,与使用泡沫敷料混合相比,使用高吸收性伤口敷料治疗中等到大量渗出性腿部溃疡的患者将导致愈合率提高 2.58%,每六个月每例患者的 HRQoL 增量为 0.143 QALWs,总直接成本节省 435 欧元(473 美元)。该评估的临床结果与管理指南一致,该指南建议高吸收性伤口敷料作为中等到大量渗出性静脉性腿部溃疡治疗的一线选择。此外,该评估还表明,从 Haute Autorité de Santé 的角度来看,使用高吸收性伤口敷料也将带来经济节省。